相关实验视频
Updated: Jul 19, 2025
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.8K
介质分子现象类型用于识别人环素诱导心脏毒性风险的遗传标记物
Aurora Gómez-Vecino1,2, Roberto Corchado-Cobos1,2, Adrián Blanco-Gómez1,2
1Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, 37007 Salamanca, Spain.
Cells
|August 11, 2023
概括
通过与心脏中介分子表型相关的遗传标记,可以识别人环素诱导的心脏毒性 (CDA) 风险. 这种方法有助于个性化的癌症患者管理,以预测和减轻心脏损伤.
科学领域:
- 基因组学就是基因组学.
- 心脏病学 心脏病学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 人环素诱导的心脏毒性 (CDA) 是癌症患者的重要并发症,但预测易感性仍然具有挑战性.
- CDA的遗传基础复杂且不完全理解,阻碍了个性化风险评估.
研究的目的:
- 调查心肌中介分子表型 (IMP) 是否可以作为CDA易感性的生物标志物.
- 识别与IMP和CDA相关的遗传变异,可以预测患者的风险.
主要方法:
- 一个遗传异质的小鼠队列被用多克索鲁比辛和多塞塔克塞尔治疗,以建模CDA.
- 量化了心脏纤维化和心脏内IMP水平.
- 使用链接分析来确定IMP (ipQTLs) 和CDA (cdaQTLs) 的定量特征位置 (QTLs).
- 在人类患者队伍中使用机器学习开发了遗传风险得分.
主要成果:
- 心肌中的IMP与小鼠的CDA显著相关.
- 结合ipQTLs和cdaQTLs的综合遗传模型解释了比单独cdaQTLs更多的CDA表型变异.
- 编码IMP的特定基因变异 (例如AKT1,TP53) 被确定为人类患者中CDA的遗传决定因素.
- 基于机器学习的基因风险评分证明了儿童和乳腺癌患者中CDA的预测价值.
结论:
- 与心脏损伤相关的中间分子表型是CDA遗传风险的有价值指标.
- 识别这些IMP相关的遗传标记可以更准确地预测CDA易感性.
- 这项研究为个性化患者管理策略铺平了道路,以减轻抗环素诱导的心脏损伤.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
119
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
201
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K